Skip to main content

Matrix Capital Management Company, LP

13F filer · CIK 0001410830
Reported Aug 13, 2026
Net seller this quarter
13F portfolio value$0U.S. long equity reported on 13F
Positions00 new · 1 closed
Net flow last quarter-$49.2MBuys minus sells
Top 10 positions weightNot reportedConcentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 20260 positions
Q1 2026Reported May 14, 20261 positions
AURAAura Biosciences, Inc.$46.3M100.00%10.79%Not reportedQ4 2021
Q4 2025Reported Feb 13, 20262 positions
AURAAura Biosciences, Inc.$37.7M65.48%10.89%Not reportedQ4 2021
MAZEMaze Therapeutics, Inc.$19.9M34.52%0.97%-71.0%Q1 2025
Q3 2025Reported Nov 13, 20253 positions
MAZEMaze Therapeutics, Inc.$42.9M40.17%3.44%-33.5%Q1 2025
AURAAura Biosciences, Inc.$42.8M40.08%10.99%Not reportedQ4 2021
ZNTLZentalis Pharmaceuticals, Inc.$21.1M19.75%19.32%Not reportedQ2 2020
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.